{"a":[{"_":"Tempus buys out cancer genomics partner Personalis in $1.5 billion deal","$":{"href":"/medtech/tempus-buys-out-cancer-genomics-specialist-personalis-15-billion-deal","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Tempus is acquiring cancer genomics specialist Personalis for $1.5 billion, three years after establishing an initial partnership to expand its oncology offerings.
Importance:8/10
Sentiment:
0.60
acquisitioncancer genomicsoncologyM&A
Related Companies
Read the original article
Published by FierceBiotech on July 20, 2026 9:12 AM